Progress toward inhibitors of metallo-β-lactamases

Future Medicinal Chemistry
Ross P McGearyGerhard Schenk

Abstract

The global overuse of antibiotics has led to the emergence of drug-resistant pathogenic bacteria. Bacteria can combat β-lactams by expressing β-lactamases. Inhibitors of one class of β-lactamase, the serine-β-lactamases, are used clinically to prevent degradation of β-lactam antibiotics. However, a second class of β-lactamase, the metallo-β-lactamases (MBLs), function by a different mechanism to serine-β-lactamases and no inhibitors of MBLs have progressed to be used in the clinic. Bacteria that express MBLs are an increasingly important threat to human health. This review outlines various approaches taken to discover MBL inhibitors, with an emphasis on the different chemical classes of inhibitors. Recent progress, particularly new screening methods and the rational design of potent MBL inhibitors are discussed.

References

Jan 1, 1997·Antimicrobial Agents and Chemotherapy·D J PayneJ Marchand-Brynaert
Dec 24, 1997·Biological & Pharmaceutical Bulletin·M GotoY Arakawa
Sep 25, 1999·Bioorganic & Medicinal Chemistry Letters·M L GreenleeJ H Epstein-Toney
Sep 30, 1999·Nature Medicine·D W Cushman, M A Ondetti
Jun 8, 2001·The Journal of Biological Chemistry·J H ToneyY D Gao
Sep 21, 2001·The Journal of Biological Chemistry·C MollardG C Roberts
Apr 2, 2003·The Journal of Biological Chemistry·Uwe HeinzHans-Werner Adolph
Apr 10, 2003·The Journal of Biological Chemistry·Isabel García-SaezOtto Dideberg
Feb 26, 2004·Bioorganic & Medicinal Chemistry Letters·John D BuynakTimothy R Walsh
Apr 16, 2005·Clinical Microbiology Reviews·Timothy R WalshPatrice Nordmann
Oct 13, 2005·Journal of the American Chemical Society·James SpencerSteven J Gamblin
Dec 28, 2005·Bioorganic & Medicinal Chemistry·Lars OlsenFlemming S Jørgensen
Oct 18, 2006·Accounts of Chemical Research·Michael W CrowderAlejandro J Vila
Feb 20, 2007·Antimicrobial Agents and Chemotherapy·L E HorsfallM Galleni
Jun 20, 2008·Organic & Biomolecular Chemistry·Benoît M R LiénardChristopher J Schofield
Jul 28, 2009·Bioorganic & Medicinal Chemistry Letters·Yukiko HiraiwaToshiaki Kudo
Dec 10, 2009·Antimicrobial Agents and Chemotherapy·Karen Bush, George A Jacoby
Mar 13, 2010·The Journal of Antibiotics·Deborah M RollMay D Lee
Jun 10, 2010·Journal of Medicinal Chemistry·Patricia LassauxCarine Bebrone
Apr 22, 2011·FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology·HongMin Zhang, Quan Hao
May 4, 2011·Bioorganic & Medicinal Chemistry Letters·Peter VellaRoss P McGeary
Nov 5, 2011·European Journal of Medicinal Chemistry·Mosaad S MohamedRania H Abd El-Hameed
Nov 26, 2011·Bioorganic & Medicinal Chemistry Letters· FaridoonRoss P McGeary
Mar 6, 2012·International Journal of Antimicrobial Agents·David M Livermore
Jun 21, 2012·Journal of the American Chemical Society·Dustin T KingNatalie C J Strynadka
Aug 28, 2012·Bioorganic & Medicinal Chemistry Letters·Pinhong ChenYongcheng Song
Aug 29, 2013·Journal of Biological Inorganic Chemistry : JBIC : a Publication of the Society of Biological Inorganic Chemistry·Peter VellaNataša Mitić
Nov 26, 2013·Bioorganic & Medicinal Chemistry Letters·Ningning LiYue Chen

❮ Previous
Next ❯

Citations

Apr 4, 2018·Current Medicinal Chemistry·Raivis Zalubovskis, Jean-Yves Winum
Oct 6, 2018·MedChemComm·Kamaleddin H M E Tehrani, Nathaniel I Martin
Mar 30, 2019·Chemical Biology & Drug Design·Cheng ShiHeng Zheng
Jun 17, 2020·Protein & Cell·Marcelo Monteiro PedrosoGerhard Schenk
Aug 14, 2019·Journal of Enzyme Inhibition and Medicinal Chemistry·Omid Khalili ArjomandiHadi Adibi
May 7, 2019·MedChemComm·Geir Kildahl-AndersenOve Alexander Høgmoen Åstrand
Sep 8, 2019·Drug Resistance Updates : Reviews and Commentaries in Antimicrobial and Anticancer Chemotherapy·João BotelhoLuísa Peixe
Apr 24, 2018·Trends in Pharmacological Sciences·Lin-Cheng JuMichael W Crowder
Sep 17, 2020·European Journal of Medicinal Chemistry·Laurent GavaraJean-François Hernandez
Jun 12, 2021·Bioorganic Chemistry·Laurent GavaraJean-François Hernandez
Jun 30, 2021·Journal of Medicinal Chemistry·Kamaleddin H M E TehraniNathaniel I Martin
Jul 20, 2018·ACS Infectious Diseases·Christian SchnaarsOve Alexander Høgmoen Åstrand
Aug 19, 2017·ACS Infectious Diseases·Kamaleddin Haj Mohammad Ebrahim Tehrani, Nathaniel I Martin
Apr 2, 2020·ACS Infectious Diseases·Kamaleddin H M E TehraniNathaniel I Martin
Dec 23, 2017·Journal of Medicinal Chemistry·Ricky CainColin W G Fishwick
Aug 23, 2019·The Journal of Organic Chemistry·Judith SynofzikMikhail Krasavin
Mar 10, 2020·Journal of Medicinal Chemistry·Scott J HeckerMichael N Dudley
Jul 27, 2021·Antimicrobial Agents and Chemotherapy·Liam A WilsonGerhard Schenk

❮ Previous
Next ❯

Methods Mentioned

BETA
x-ray crystallographic
x-ray crystallography
NMR
x-ray

Related Concepts

Related Feeds

Beta-lactamase Inhibitors (ASM)

Beta-lactamase inhibitors are a class of antibiotics that inhibit beta-lactamases, a family of enzymes involved in bacterial resistance to beta-lactam antibiotics. Here is the latest research.

Antifungals (ASM)

An antifungal, also known as an antimycotic medication, is a pharmaceutical fungicide or fungistatic used to treat and prevent mycosis such as athlete's foot, ringworm, candidiasis, cryptococcal meningitis, and others. Discover the latest research on antifungals here.

Antifungals

An antifungal, also known as an antimycotic medication, is a pharmaceutical fungicide or fungistatic used to treat and prevent mycosis such as athlete's foot, ringworm, candidiasis, cryptococcal meningitis, and others. Discover the latest research on antifungals here.

Beta-lactamase Inhibitors

Beta-lactamase inhibitors are a class of antibiotics that inhibit beta-lactamases, a family of enzymes involved in bacterial resistance to beta-lactam antibiotics. Here is the latest research.

Related Papers

FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology
HongMin Zhang, Quan Hao
© 2022 Meta ULC. All rights reserved